S.Africa’s Aspen plans to buy infant nutritional business from Nestle

Your Health Matters

(Blank Headline Received)JOHANNESBURG (Reuters) – South Africa's Aspen Pharmacare has plans to buy Nestle South Africa's infant nutritional business for $215 million, the company said on Thursday. The deal gives it certain rights to intellectual property licenses, net assets and shares currently conducted by Pfizer.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave